GILD vs TRV · P/E 18, rev $7.80B vs P/E 14, rev $12.15B
Gilead Sciences Inc (GILD) versus The Travelers Companies Inc (TRV) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
The Travelers Companies Inc (TRV) is a insurance - property & casualty company listed on US.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported TRV revenue for 2026-06-30 was $12.15B. Net income was $2.21B. Revenue was up 1.9% from 2026-03-31 to 2026-06-30. TRV currently screens at market cap $59.84B and trailing P/E 14.4.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. TRV currently screens at market cap $59.84B and trailing P/E 14.4.
Not investment advice. Open the GILD and TRV stock pages for the full models.
Not investment advice.